AXON PARTNERS GRP EO -10
Axon Partners Group, S.A. is a private equity and venture capital firm specializing in all stages from seed to growth capital, growth equity, startups, lower middle market, early stage, pre-IPO, IPO, post IPO, expansion, mid venture, late venture sustainability, debt instrument, private debt and fund of funds investment. Within fund of funds, the firm seeks to invest in all sectors and stages fro… Read more
AXON PARTNERS GRP EO -10 (XE1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, AXON PARTNERS GRP EO -10 (XE1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
AXON PARTNERS GRP EO -10 - Net Assets Trend (None–None)
This chart illustrates how AXON PARTNERS GRP EO -10's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AXON PARTNERS GRP EO -10 (None–None)
The table below shows the annual net assets of AXON PARTNERS GRP EO -10 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to AXON PARTNERS GRP EO -10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
AXON PARTNERS GRP EO -10 Competitors by Market Cap
The table below lists competitors of AXON PARTNERS GRP EO -10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nykredit Invest Ansv Kreditobl
CO:NYIAKO
|
$144.67K |
|
Blonder Tongue Laboratories Inc
PINK:BDRL
|
$144.72K |
|
ECKERT & ZIEGLER
BE:EUZ
|
$144.73K |
|
M'BISHI UFJ FINL
HM:MFZ
|
$144.83K |
|
RACL Geartech Limited
NSE:RACLGEAR
|
$144.64K |
|
MINEBEA (MEA.SG)
STU:MEA
|
$144.60K |
|
PT Perma Plasindo Tbk
JK:BINO
|
$144.58K |
|
CVS GROUP
BE:4C9
|
$144.49K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AXON PARTNERS GRP EO -10's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares AXON PARTNERS GRP EO -10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently AXON PARTNERS GRP EO -10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares AXON PARTNERS GRP EO -10's net assets metrics with peer companies in the Consulting Services industry.
Industry Context
- Industry: Consulting Services
- Average net assets among peers: $361,756,429
- Average return on equity (ROE) among peers: -71.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AXON PARTNERS GRP EO -10 (XE1) | €- | N/A | N/A | $144.64K |
| Palgon AG (3D6) | $151.52K | -61.78% | 0.06x | $55.05K |
| Rejlerkoncernen AB (3RE) | $1.94 Billion | 11.45% | 0.91x | $274.54 Million |
| RC Fornax Plc (8AD) | $108.00K | 533.33% | 12.88x | $670.36K |
| Avemio AG (AV2) | $161.06K | -862.69% | 0.03x | $5.08K |
| Natus Medical Incorporated (NM4) | $56.82 Million | -60.23% | 2.45x | $2.29 Million |
| Ricardo plc (RIR) | $176.50 Million | 10.65% | 0.92x | $168.54 Million |